Founded in 2001, Linguamatics is a world-leader in deploying innovative natural language processing (NLP)-based text mining for high-value knowledge discovery and decision support. We aim to produce software and solutions to help the pharma-biotech and healthcare industries speed up the drug-discovery cycle and improve patient outcomes. Linguamatics partners and collaborates with numerous companies, academic and governmental organizations, to bring customers the right solution for their needs and to develop next generation capabilities. I2E is used by 17 of the top 20 global pharmaceutical organizations* plus many other pharmaceuticals and biotechs in the Scripp 100. I2E text mining is opening up the vast amount of data held in Electronic Heath Records, providing an invaluable resource for research and patient care. In 2014, due to our success, we won the Queen's Award for Enterprise in International Trade. Linguamatics is a young, rapidly growing company with headquarters in Cambridge, UK and expanding operations in the US.
Is this your company?
Add websites to boost your visibility.Ask for a quote